EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Diagnostic value of nanopore-based metagenomic third-generation sequencing in the diagnosis of Pneumocystis jirovecii infection in patients with lung cancer

Yuyan Luo, Wei Cheng, Lei Ma, Tiantian Wang, Weirong Shi

Journal of Medical Microbiology · 2025

DOI: 10.1099/jmm.0.002031 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Medical Microbiology, 2025. Verfasst von Yuyan Luo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Affiliated Nantong Hospital of Shanghai University, Nantong, Jiangsu 226001, PR China. Hauptthemen laut MEDLINE: Lung Neoplasms, Pneumonia, Pneumocystis, Pneumocystis carinii, Metagenomics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pneumocystis jirovecii pneumonia (PJP, formerly known as Pneumocystis carinii pneumonia), an opportunistic fungal infection caused by the fungus P. jirovecii , is a severe pulmonary infection that primarily affects immunocompromised patients, including those with lung cancer. Traditional diagnostic methods for PJP, such as Grocott–Gomori’s methenamine silver staining and real-time PCR, have limitations, including low positivity and high missed diagnosis rates. Gap Statement. Despite the critical need for accurate and sensitive diagnostic tools for PJP, especially in immunocompromised populations, existing methods fall short in providing the necessary reliability and efficiency.

Aim

This study aims to evaluate the efficacy of nanopore-based metagenomic third-generation sequencing in diagnosing P. jirovecii infection in lung cancer patients, hypothesizing that this approach may offer superior sensitivity and specificity. Methodology. A prospective observational study was conducted on 118 lung cancer patients with suspected pulmonary P. jirovecii infection at the Sixth Hospital of Nantong City, China, from January 2021 to December 2023. The identification of pathogens in bronchoalveolar lavage fluid samples was performed using both metagenomics and traditional tests.

Results

Metagenomics showed a significantly higher detection rate of P. jirovecii (33.0%) compared to methenamine silver staining (4.2%) and real-time PCR (30.5%). The sensitivity, specificity and accuracy of metagenomics detection were all 100%, which is markedly superior to traditional methods. Furthermore, metagenomics also identified mixed infections with other pathogens, such as Cytomegalovirus and Epstein–Barr virus.

Conclusion

Metagenomics technology demonstrates high sensitivity and specificity in diagnosing P. jirovecii infection, including mixed infections with other pathogens, in lung cancer patients. It provides a clear direction for clinical treatment and is a powerful tool for diagnosing PJP, contributing to improved diagnostic efficiency and accuracy, reducing misdiagnosis and missed diagnosis rates and improving clinical outcomes in these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsPneumonia, PneumocystisPneumocystis cariniiMetagenomicsNanopore SequencingHumansMaleFemaleMiddle AgedAgedProspective StudiesSensitivity and SpecificityBronchoalveolar Lavage FluidHigh-Throughput Nucleotide SequencingAdultAged, 80 and overChina

Stichwörter der Autor:innen

Pneumocystis jiroveciidiagnosislung cancermetagenomicsnanopore-based third-generation sequencing

Autor:innen und Institutionen

  • Department of Medical Oncology, Affiliated Nantong Hospital of Shanghai University, Nantong, Jiangsu 226001, PR China.
  • Department of Respiratory Diseases, Tongzhou People's Hospital, Nantong, Jiangsu 226300, PR China.
  • Department of Respiratory Diseases, Affiliated Nantong Hospital of Shanghai University, Nantong, Jiangsu 226001, PR China.
  • Department of Thoracic Surgery, Affiliated Nantong Hospital of Shanghai University, Nantong, Jiangsu 226001, PR China.

Zitieren

APA

Luo, Y., Cheng, W., Ma, L., Wang, T., & Shi, W. (2025). Diagnostic value of nanopore-based metagenomic third-generation sequencing in the diagnosis of Pneumocystis jirovecii infection in patients with lung cancer. Journal of Medical Microbiology. https://doi.org/10.1099/jmm.0.002031

Vancouver

Luo Y, Cheng W, Ma L, Wang T, Shi W. Diagnostic value of nanopore-based metagenomic third-generation sequencing in the diagnosis of Pneumocystis jirovecii infection in patients with lung cancer. Journal of Medical Microbiology. 2025. doi:10.1099/jmm.0.002031

BibTeX
@article{Luo2025,
  author = {Luo, Yuyan and Cheng, Wei and Ma, Lei and Wang, Tiantian and Shi, Weirong},
  title = {Diagnostic value of nanopore-based metagenomic third-generation sequencing in the diagnosis of Pneumocystis jirovecii infection in patients with lung cancer},
  journal = {Journal of Medical Microbiology},
  year = {2025},
  doi = {10.1099/jmm.0.002031}
}
Kostenlos starten →